DFINE Management Team

Greg Barrett
President and Chief Executive Officer
Greg has over 35 years of medical device experience. Within the medical device market he has worked in the fields of gastroenterology, urology, cardiology, cardiovascular surgery and general surgery. Most recently Greg was the Chairman, President and CEO of BÂRRX Medical a private medical device company recently acquired by Covidien. BÂRRX manufactures and distributes products to treat gastrointestinal diseases with specific focus on diseases of the esophagus. 

Prior to joining BÂRRX Medical, Inc., Greg served as President and CEO of ACMI Corporation which was acquired by Gyrus Medical. Greg was previously a Group Executive Vice President at Boston Scientific Corporation with responsibilities at various times over the Microvasive Endoscopy, Microvasive Urology and Intercontinental International businesses. Greg has also held senior management positions at both Orthofix Corporation and Baxter Healthcare. He also spent 13 years at C.R. Bard Corporation and finished his tenure as Vice President of marketing in the Cardiosurgery Division.

Greg currently sits on the Board of Directors for Monteris Medical focused on the treatment of brain tumors, and Cutera, Inc. a public medical device company in the aesthetics market. 

Greg holds a B.A. in Marketing from the University of Texas, Austin.

Tim L. Lanier
Vice President of Sales, US

Tim Lanier has over 25 years of sales experience in the medical device industry. Before joining DFINE, Lanier was Vice President of US Sales, Covidien Endovascular; a leader in treating vascular disease.  At Covidien he built a world-class sales organization responsible for driving US sales to $473M with over 400 sales personnel while meeting financial objectives. He was successful in leading the organization through the acquisition of FoxHollow Technologies. In addition, he merged the Endoarterial and Endovenous businesses at Covidien to form the Endovascular Sales organization. Lanier has also held executive positions at Anulex Technologies and Zimmer Spine/Spine Tech as their Vice President of US Sales. Lanier holds a Bachelor of Science in Business Administration from the University of La Verne, La Verne, CA.


Cindee Van Vleck
Vice President of Global Human Resources

Cindee has over 25 years Human Resources Management experience, with time spent in both the medical device and high tech industries.  Prior to joining DFINE, Cindee was the Vice President of Global Human Resources for OCZ Storage Solutions, Inc.,  which was recently acquired by the Toshiba Group.  In that role, as a member of the executive staff, she led a global HR team that had their headquarters in California with branch offices in Europe and Taiwan, as well as subsidiaries in Canada, South Korea, the UK, and Israel.  Before joining OCZ, she was the Senior Director of Human Resources for VNUS Medical Technologies, Inc.  During her time at VNUS, as a member of the executive team, she led the Human Resources department, programs, and policies as they grew from 36 to 330 employees, resulting in a successful IPO and subsequent acquisition by Covidien.  Earlier in her career, she held positions in Human Resources and Administration at both Amdahl Corporation and Kyocera International, Inc.  Cindee is a graduate of San Jose State College / Excelsior College with a BS in Business Administration / Human Resources Management.


Douglas M. Petty
Senior Vice President of Marketing

Doug has over 25 years of sales and marketing experience in the medical device industry. Most recently, he was VP of Global Marketing at Thoratec Corporation, a leader in cardiovascular devices for advanced heart failure. During his time at Thoratec he built a world class marketing organization responsible for the successful worldwide launch of the Heartmate II LVAS platform which helped drive the firm's revenue to over $280M. Previously, Doug was VP of Global Marketing for Electrophysiology and Cardiovascular Imaging at Boston Scientific where he helped grow the division's revenue to over $130M along with leading key technology and business development initiatives. He also served as Director of Global Sales and Marketing for VNUS Medical Technologies. As one of the original members of the executive team, he helped to successfully create the market for minimally invasive treatment of venous disease, which led to a successful IPO and subsequent acquisition by Covidien. He has also held executive marketing positions at Vitaphore, EP Technologies and Medical Innovations. Doug is a graduate of the University of Illinois' School of Business Administration.

Robert D. Poser, D.V. M.
Vice President of Scientific and Medical Affairs

Dr. Poser has over 20 years of experience in medical device development at Baylor College of Medicine, Harrington Arthritis Research Center, Norian Corporation and Corazon Technologies. Following completion of his D.V.M. at the University of Georgia and postdoctoral clinical training, Dr. Poser completed a non-clinical fellowship in orthopedic surgery and science with a focus on biomaterials, implant design, periprosthetic bone remodeling and device product development. Upon completing his fellowship Dr. Poser was appointed Head of the Experimental Surgery at the Harrington Arthritis Research Center. Recruited to industry, he joined Norian Corporation and served as Vice President of Research and Development, directing innovative applied research and clinical application of novel calcium phosphate cement technology. Dr. Poser served as a consultant to the medical device industry prior to becoming Vice President of Science and Technology at Corazon Technology, developing minimally invasive biomimetic technology for preferential demineralization of calcific cardiovascular tissue. He joined DFINE as Vice President of Scientific and Medical Affairs in November, 2005. Dr. Poser is well published and holds numerous patents in the field of medical device innovation.

Dan Balbierz
Chief Development Officer

Dan is a seasoned executive with over 28 years of medical device experience, who has worked in small entrepreneurial companies, as well as Fortune 500 corporations.  Prior to joining DFINE, Dan served as the President  & CEO, and member of the Board of Directors, of BaroSense, Inc.,  a company focused on minimally invasive devices for the treatment of obesity.  Prior to BaroSense, Dan served as the Vice President, Research and Development of RITA Medical Systems, leading the regulatory, clinical and R&D groups, pioneering advances in tumor ablation. RITA Medical Systems had a successful IPO in June of 2000.  Before RITA Medical, Dan held the position of Worldwide Director, Research and Development for the Vascular Access Division of Johnson & Johnson Medical, Inc.  Early in his career Dan held various engineering and management roles at Menlo Care, (acquired by Johnson & Johnson) and American Pharmaseal.

Dan currently sits on the Board of Directors for BaroNova, a clinical-stage medical-technology company developing endoscopically-delivered devices for the chronic treatment of obesity.
Dan holds a BSME from California Polytechnic State University and is the author of over 100 patents and patent applications in the medical device field

Robert H. Founds
Vice President of Quality Assurance and Regulatory Affairs
Bob has over 20 years of Quality and Regulatory experience in the medical device industry.  Bob has held leadership positions with small venture-backed medical device companies including NFocus Neuromedical and AirXpanders as well as large Fortune 500 medical device companies including Varian Medical Systems and St. Jude Medical.  Most recently, he served as Sr. Director of Quality Assurance at Accuray, Inc., a leader in the field of radiation therapy and radiosurgery.  Bob holds a master’s degree in electrical engineering from the University of Idaho.

Patrick Mercer
Vice President, Manufacturing and Logistics

Patrick joined DFINE in 2008 and has over 12 years of experience working in medical device manufacturing and engineering at companies such as Kimberly-Clark, Stryker, Revivant Corp/Zoll Medical, and Hemosense / Inverness Medical Innovations. Patrick's work experience covers medical device companies from start-ups to large, highly established companies. While serving in various engineering and manufacturing positions, Patrick has overseen the design and implementation of new manufacturing processes and products, including management of overseas services and production facilities in Eastern Europe, China and Australia. As Director of Engineering and Manufacturing with Hemosense, he was instrumental in delivering 100% increase in production capacity that resulted in a $4.5 million savings to the company. At Revivant, the manufacturing processes he created were instrumental in Zoll Medical's decision to acquire the company. Patrick graduated from the University of Alabama with a BSEE, Magna Cum Laude, Electrical Engineering / Computer Engineering. Prior to entering college, Patrick proudly served in the Nuclear Power Program of the US Navy.

Linda M. Lechner
Corporate Compliance Officer

Linda has over 25 years of experience in finance and administration, primarily in the medical diagnostic industry. Most recently, she held the position of Chief Financial Officer/Vice President of Administration at Microgenics Corporation, a medical diagnostic company focused on developing and manufacturing diagnostic assays using multiple technologies. At Microgenics, Linda was responsible for managing the entire financial, IT and Human Resources functions of the Company as well as three subsidiaries. The company began as a start-up and throughout her eight years there, went through several mergers and acquisitions. Linda was instrumental in bringing the new companies together- from both a personnel and a systems approach. She has extensive experience not only with mergers and acquisitions, but ERP system implementations, establishing internal controls and providing reliable financial information. Prior to Microgenics, Linda was the Controller for Boehringer Mannheim. Linda holds a BS in Accounting from Rochester Institute of Technology.